Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Feb 14.
Published in final edited form as: Neurology. 2007 May 22;68(21):1815–1819. doi: 10.1212/01.wnl.0000262036.56594.7c

Measles virus–specific plasma cells are prominent in subacute sclerosing panencephalitis CSF

GP Owens 1, AM Ritchie 1, DH Gilden 1, MP Burgoon 1, D Becker 1, JL Bennett 1
PMCID: PMC3278989  NIHMSID: NIHMS353906  PMID: 17515543

Abstract

Objective

To demonstrate the specificity of expanded CD138+ plasma cell clones recovered from the CSF of a patient with subacute sclerosing panencephalitis (SSPE) for measles virus (MV).

Methods

IgG variable region sequences of single-antibody-secreting CD138+ cells sorted from SSPE CSF were amplified by single-cell PCR and analyzed. Human IgG1 recombinant antibodies (rAbs) were produced from four expanded CD138+ clones and assayed for immunoreactivity against MV proteins.

Results

Clonal expansion was a prominent feature of the SSPE plasma cell repertoire, and each of the four rAbs assayed was specific for either the MV fusion or the MV nucleocapsid protein.

Conclusions

Expanded plasma cell clones in the CSF of patients with subacute sclerosing panencephalitis produce disease-relevant antibodies. Recombinant antibodies derived from CSF B cells could provide a tool to identify target antigens in idiopathic inflammatory disorders.


Features of chronic inflammatory and infectious CNS diseases include increased intrathecal immunoglobulin (Ig) G synthesis, the presence of oligoclonal bands, and recruitment and expansion of B lymphocytes and CD138+ plasma cells within the CNS.14 When the specificity of these antibody responses has been studied, the oligoclonal IgG has been shown to be directed against the causative agent.5 To demonstrate whether clonally expanded and differentiated plasma cells in subacute sclerosing panencephalitis (SSPE) CSF are disease relevant, we produced recombinant antibodies (rAbs) from variable (V) region sequences of expanded CD138+ clones and assayed their specificity for measles virus (MV).

CASE REPORT

A 12-year-old Caucasian boy born in Albania had a 1-year history of decline in school grades and increasingly disruptive and aggressive behavior. Two weeks before hospitalization, he became anorexic, lethargic, and drowsy. Two days before presentation, he began to exhibit bilateral jerking of his limbs, mostly in his arms. He had experienced various childhood exanthems before age 5, but a definitive diagnosis of measles was not made. At age 5, he moved to the United States and received vaccinations including measles vaccine. The neurologic examination on admission revealed drowsiness and orientation only to person. Although regarded as a good English speaker, he could follow commands only in his native language. Rhythmic whole-body flexion movements were observed every 5 to 7 seconds. Muscle tone and strength were normal. Coordination was impaired in all extremities, and his gait was wide-based. Deep tendon reflexes were normal, and there were no pathologic reflexes. Brain MRI revealed multiple foci of increased T2-weighted signal in the subcortical white matter and adjacent cortex. There was no enhancement or restricted diffusion. An EEG revealed generalized periodic discharges, typically lasting less than 1 second, every 5 to 7 seconds. The CSF was clear and colorless and contained seven cells, all mononuclear; CSF glucose was 62 mg%, protein was 40 mg%, IgG was 23.7 mg%, and there were 17 oligoclonal bands as determined by isoelectric focusing and immunodetection with anti-human IgG. The IgG/protein ratio in CSF was 59%. The diagnosis of SSPE was confirmed by the detection, on two separate occasions, of high titers of antibody to MV: ELISA value >7.00 (Arup Laboratories, Salt Lake City, UT) and >8.00 (University of Colorado Hospital, Denver, CO) in both serum and CSF

CD19+ B lymphocytes and CD138+ antibody–secreting cells were sorted from CSF as described.6 After gating for cells in the approximate size range of lymphocytes and plasma cells, CD19+ or CD138+ cells were separated from CD3+ T cells and individually sorted into each well of a 96-well PCR plate. The CD19+ and CD138+ populations accounted for 3.9 and 1.25% of the mononuclear cell fraction, respectively, values comparable with those found in CSF of patients with multiple sclerosis (MS),2,4,6 optic neuritis,7 and other infectious CNS diseases.4 Although levels of intrathecal IgG synthesis in SSPE can be an order of magnitude greater than those found in MS, this difference probably reflects an overall increase in the number of CSF lymphocytes rather than a shift in mononuclear cell populations toward the B cell lineage. Co-expression of CD19 by CD138+ cells was variable and represented a continuum from CD19+-expressing plasmablasts to CD19, CD138+ plasma cells (data not shown). Like CSF from MS and other CNS inflammatory diseases,4 most CD138+ cells expressed an intermediate level of CD19, indicating that plasmablasts were the prominent antibody-secreting B cell in SSPE CSF.

Immediately after cell sorting, cDNA was synthesized from single CD138+ cells, heavy (H) and light (L) chain V regions were amplified using established PCR primers and a nested PCR protocol, and PCR products were purified and sequenced with appropriate constant region antisense primers.6,8 The features of H and L chain V regions recovered from 71 different CD138+ cells categorized according to their H and L chain CDR3 amino acid sequence (table) were similar to those found in B lymphocytes and plasma cells from MS and optic neuritis CSF.69 Clonal expansion was prominent with 50 of 71 IgG-expressing CD138+ cells found within clonal populations. Seven different plasma cell clones were identified in which each cell within a clone expressed the same VH and VL germline rearrangements. The only exception was clone 5, where cells expressing the same H chain sequence expressed one of two different functional L chain rearrangements. Clone 1 was large and accounted for almost one-half of CD138+ cells analyzed. Alignment of each V region to human germline sequences in VBASE identified the most homologous germline segment and the extent of somatic mutation. Although germline segments from most VH families were observed in this repertoire, those from the VH1 family were utilized most often and represented 12 of 28 (43%) of the unique VDJ rearrangements. In normal peripheral blood, VH1 H chains are found in about 20% of naive B cells, reflecting their genomic prevalence. Skewing of the SSPE repertoire toward VH1 germlines most likely reflects antigenic selection by MV eptitopes. All H chains demonstrated varying degrees of somatic mutation (87 to 98.3%) from their respective germline segment. L chains were about equally distributed between kappa and lambda chains and also exhibited some degree of somatic mutation, although usually to a lesser extent than the paired H chain sequence.

Table.

Features of V region sequences amplified from single CD138+ plasma cells sorted from subacute sclerosing panencephalitis IC06-1 CSF*

CDR3 - VH No. Family VH Homol, % CDR3 - VL Family VL Homol, %
Clone 1
 GTFSEWLRSFYFDS 31 VH1 1–69 92.9 QQYNNYTPA VK1 L12a 94.3
Clone 2
 DRAAGLGRFGMDV 6 VH4 4–59 89.3 QQSHTFPRT VK1 L5 92.3
Clone 3
 ESPAKKSFGVVVLRHGMDV 3 VH3 3–48 93.2 QTWDSGRV VL4 4b 94.4
Clone 4
 DDGNTRDGYKLDC 3 VH3 3-21 93.2 GADHNDGNKFVWW VL9 9A 98
Clone 5
 GASEQQLSHSFYYYGLDV 2 VH4 4-31 92.3 QQYDNLPLFT VK1 O18 94.3
 GASEQQLSHSFYYYGLDV 1 92.3 MQRIEFPWT VK2 O1 98.3
Clone 6
 HVWDDSSGYYRWAKIDY 2 VH4 4-59 95.9 MQVLQTPLS VK2 A3 98.3
Clone 7
 VARFDAFNI 2 VH3 3-72 96.3 SSWDDSLSGRV VL1 1g 97.9
Single Sequences
 DVVAKDKAAAGAFGMDV VH1 1-69 92.9 QQRSNWREYT VK3 ND
 HEGAGLSSGYPQTTHFEY VH5 5-51 98.3 WSYAGRNTYWW VL2 2b2 96.2
 CSKSRNWNDGRIFGLDV VH1 ND QDLKSYPSFT VK1 L8 93.5
 RSGQWLARSYQYYYGMDV VH3 3-30 93.9 MQALQTPPA VK2 A3 98.6
 QYDILTGGY VH3 3-15 97
 DQAYDTIGYYYGDL VH1 1-18 92.5 QQSGTSPPWT VK3 A27 98.2
 FVLMVYDDLHSYYYGMDV VH3 3-48 95.2 SSYTDSPTPLL VL2 2a2 96.9
 ARYFSGSMSFDS VH3 3-23 94.2 GTWDSSLSAPWV VL1 1b 98.6
 SSLSVAGTRGYFDL VH1 1-69 94.2
 ALYDEYIRGVWFDS VH1 1-69 86.9 QQYNSYSVT VK1 L12a 94.3
 NRAYIYGADAFDV VH3 3-30 90.1
 DRGGIMPPLIYQYFGLDV VH1 1-02 90.5 SSYTTSGTPIV VL2 2a2 90
 GPSSPTPIQTDD VH3 3-23 87 SAWDDSLSGVV VL1 1b 91
 ALGKGNAYYYHYGMDV VH3 3-23 97.6 AAWDDSLNVYYV VL1 99
 VKTGLITMVRGDIENAFDI VH1 1-02 99 GTWDSSLSAPWV VL1 99.6
 NPDYGSGGLTLDY VH5 5-51 95.9
 VRSAYRGVPLA VH1 1-69 89.6 HQYATTATWT VK3 93.4
 DRAGKYYGSGSYMFDS VH1 ND
 SHHRGTQFLEWLLHD VH1 1-e 89.8 QQVNSFPLT VK1 95.4
 EGAGFDFWSGSSSSNYYGLDV VH1 1-e 90.1 QQYYASPNT VK4 97.3
 VAHSFEPRFGVVMGWFDP VH5 5-51 97.6 QQYYNT PFT VK4 99
*

Each row indicates the heavy and light chain CDR3 amino acid sequence, the number of CD138+ cells expressing that rearrangement, the most homologous human V region family and germline segment (VH or VL indicated by locus), and the homology (Homol) of each V region sequence to that germline.

ND = not done.

We constructed bivalent human IgG1 monoclonal rAbs from the three most prominent plasma cell clones (clones 1, 2, 3) and from less abundant sequences (clone 6). Cloning of H and L chain V region sequences into the pIgG1-Flag and pCEP4 expression vectors, respectively, transfection of HEK 293 cells, and rIgG purification from tissue culture supernatants have been described.10,11 Production and purification of disulfide-bonded rIgG was verified by sodium dodecyl sulfate polyacryl-amide gel electrophoresis and immunoblotting under nonreducing conditions (data not shown).

RESULTS

IgG purified from the patient’s CSF and each CSF-derived rAb was assayed for MV immunoreactivity by staining acetone-fixed MV-infected and -uninfected Vero cells (figure 1).10 rIgGs representing clones 1 to 3 intensely stained MV-infected multinucleated giant cells, but not uninfected Vero cells. Clone 6 rIgG did not stain MV-infected cells (data not shown). To identify the specific proteins recognized by the MV-positive rIgGs, Vero or HEK 293 cells transfected with the MV nucleocapsid (N), fusion (F), hemaglutinin (H), and phosphoprotein (P) genes were stained with the individual rIgGs. Clone 1 rIgG stained transfected cells expressing the MV-F protein, but not control cells or cells expressing other MV genes, whereas clones 2 and 3 stained only cells transfected with the MV-N gene (shown in figure 1 for MV-N- or MV-F- transfected cells).

Figure 1.

Figure 1

Recombinant antibodies derived from expanded CD138+ clones in SSPE CSF immunostain MV–infected cells

Purified recombinant IgG (10 μg/mL) from CD138+ clones 1 to 3 and subacute sclerosing panencephalitis (SSPE) CSF IgG stained measles virus (MV)-infected Vero cells, but not uninfected cells. Further immunostaining of Vero or HEK 293 cells transfected with cDNAs of individual MV proteins revealed reactivity of clone 1 rIgG with the MV fusion (MV-F) protein and reactivity of clones 2 and 3 rIgG with the MV nucleocapsid (MV-N) protein. CSF IgG from the patient with SSPE also stained both MV-N and MV-F transfected cells. Immunostaining was detected using a 1:500 dilution of goat anti-human IgG conjugated to alkaline phosphatase (Vector Laboratories, Burlingame, CA) with Vector new fuschin as substrate. Coverslips were counterstained with hematoxylin.

Immunoblot analysis (figure 2) showed that clone 3 rIgG recognized a 60-kd protein in MV-infected cell lysates corresponding in size to the MV-N protein. Clone 1 and clone 2 rIgG did not react with their target MV proteins under denaturing conditions. Interestingly, clone 6 rIgG, which failed to recognize MV by immunostaining, showed weak reactivity to a approximately 60-kd protein in the MV lysate that comigrated with MV-N protein recognized by clone 3 (figure 2). This suggests that clone 6 rIgG is reactive against a MV-N protein epitope that is better exposed under denaturing conditions. None of the rIgGs or SSPE brain IgG reacted to proteins in the uninfected Vero cell lysate.

Figure 2.

Figure 2

Immunoblot detection of MV–specific proteins with SSPE CSF-derived rAbs

Measles virus (MV)-infected or -uninfected Vero cell lysates (15 μg/lane) were separated in a 10% sodium dodecyl sulfate polyacrylamide gel, transferred to nitrocellulose, and probed with each subacute sclerosing panencephalitis (SSPE) recombinant antibodies (rAb) (5 μg/mL) or with IgG eluted from SSPE brain. Antibody binding to MV proteins was detected using a 1:500 dilution of goat anti-human IgG conjugated to alkaline phosphatase. Under denaturing conditions, clones 1 and 2 rIgG did not recognize the MV-F or MV-N protein, whereas clone 3 rIgG did recognize a 60-kd MV protein. Although clone 6 rIgG did not immunostain MV-infected cells, it was weakly reactive with a 60-kd protein found only in the infected cell lysate, suggesting that clone 6 rIgG may also be directed against the MV-N protein. SSPE brain IgG also identified several MV-specific proteins.

DISCUSSION

SSPE is a chronic encephalitis caused by persistent MV infection of neurons and glia. Our patient’s neurologic features, mildly inflammatory CSF, oligoclonal bands, and high titers of antibody to MV in both serum and CSF, are characteristic of SSPE. Most cases occur in children and teenagers with a history of measles infection, often before age 2; rarely, SSPE occurs in a child after vaccination.12 In our patient, it is unknown whether vaccination represented his initial exposure to MV.

High titers of MV-specific antibody are present in the SSPE brain and CSF13 as a result of the diffuse infiltration of lymphocytes and plasma cells into the brain parenchyma.14 Sequence analysis of rearranged Ig genes amplified from SSPE brain cDNA libraries1 and single microdissected CD38+ cells10 reveals a limited H chain repertoire with prominent clonal expansion and somatic hypermutation indicative of a CNS-targeted humoral response to MV. In this study, we demonstrate that a similar MV-targeted humoral immune response is identifiable in CSF of SSPE patients and that the specificity of this response can be characterized from a small amount of CSF using recombinant antibody technology.

CSF is more readily accessible than brain tissue and thus is routinely used to monitor ongoing immunity in CNS inflammatory diseases. In this study, we demonstrate that three of four rAbs derived from expanded CD138+ clones in SSPE CSF react to MV proteins, providing a link between intrathecal synthesis of MV-specific IgG and the expansion and migration of antibody-secreting cells in brain. Although the precise relationship between expanded B and plasma cell clones and oligoclonal bands requires further comparison, it is clear that B cells found in both brain parenchyma and CSF are components of the same antigen-targeted humoral response. The recent discovery of ectopic germinal centers in the meninges of some MS patients15 and the enrichment of B cell subsets with phenotypes characteristic of germinal center reactions3 in MS and non-MS inflammatory CSF suggest that B cell differentiation into antibody-secreting plasma cells may be sustained within the CNS in chronic inflammatory disorders. In conclusion, our current data show that CD138+ cells recovered from SSPE CSF are primarily targeted against disease-relevant antigens. Equivalent techniques and strategies can be used to identify unknown antigens or to monitor ongoing immunity in other CNS inflammatory diseases.

Acknowledgments

The authors thank Marina Hoffman for editorial assistance and Cathy Allen for manuscript preparation.

Supported in part by Public Health Service grants NS32623 (G.P.O., D.H.G., M.P.B., J.L.B) and EY014573 (J.L.B.) from NIH and grant RG3908 (J.L.B.) from the National Multiple Sclerosis Society.

Footnotes

Disclosure: The authors report no conflicts of interest.

References

  • 1.Smith-Jensen T, Burgoon MP, Anthony J, et al. Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology. 2000;54:1227–1232. doi: 10.1212/wnl.54.6.1227. [DOI] [PubMed] [Google Scholar]
  • 2.Cepok S, Jacobsen M, Schock S, et al. Patterns of cerebro-spinal fluid pathology correlate with disease progression in multiple sclerosis. Brain. 2001;124:2169–2176. doi: 10.1093/brain/124.11.2169. [DOI] [PubMed] [Google Scholar]
  • 3.Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA. 2004;101:11064–11069. doi: 10.1073/pnas.0402455101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cepok S, Rosche B, Grummel V, et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain. 2005;128:1667–1676. doi: 10.1093/brain/awh486. [DOI] [PubMed] [Google Scholar]
  • 5.Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol. 2005;4:195–202. doi: 10.1016/S1474-4422(05)01017-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ritchie AM, Gilden DH, Williamson RA, et al. Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol. 2004;173:649–656. doi: 10.4049/jimmunol.173.1.649. [DOI] [PubMed] [Google Scholar]
  • 7.Haubold K, Owens GP, Kaur P, et al. B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid. Ann Neurol. 2004;56:97–107. doi: 10.1002/ana.20152. [DOI] [PubMed] [Google Scholar]
  • 8.Owens GP, Ritchie AM, Burgoon MP, et al. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol. 2003;171:2725–2733. doi: 10.4049/jimmunol.171.5.2725. [DOI] [PubMed] [Google Scholar]
  • 9.Monson NL, Brezinschek HP, Brezinschek RI, et al. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol. 2005;158:170–181. doi: 10.1016/j.jneuroim.2004.04.022. [DOI] [PubMed] [Google Scholar]
  • 10.Burgoon MP, Keays KM, Owens GP, et al. Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc Natl Acad Sci USA. 2005;102:7245–7250. doi: 10.1073/pnas.0502323102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yu X, Gilden DH, Ritchie AM, et al. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J Neuroimmunol. 2006;172:121–131. doi: 10.1016/j.jneuroim.2005.11.010. [DOI] [PubMed] [Google Scholar]
  • 12.Modlin JF, Jabbour JT, White JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics. 1977;59:505–512. [PubMed] [Google Scholar]
  • 13.Connolly JH, Allen IV, Hurwitz LJ, Miller JD. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet. 1967;1:542–544. doi: 10.1016/s0140-6736(67)92117-4. [DOI] [PubMed] [Google Scholar]
  • 14.ter Meulen V, Katz M, Muller D. Subacute sclerosing panencephalitis: a review. In: Arber W, Braun W, Haas R, editors. Current topics in microbiology and immunology. Berlin: Springer-Verlag; 1972. pp. 1–38. [DOI] [PubMed] [Google Scholar]
  • 15.Serafini B, Rosicarelli B, Magliozzi R, et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004;14:164–174. doi: 10.1111/j.1750-3639.2004.tb00049.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES